What's Happening?
The New York Yankees are actively exploring the trade market to bolster their pitching lineup due to injuries to key players. With Gerrit Cole, Carlos Rodon, and Clarke Schmidt sidelined following elbow surgeries, the Yankees have shown interest in Miami Marlins' right-hander Edward Cabrera. Cabrera, who debuted with the Marlins in 2021, is under team control through 2028 and is projected to earn $3.7 million in arbitration in 2026. Despite his potential, Cabrera's recent history includes stints on the injured list due to a right middle finger blister and a sprained right elbow. The Yankees are also considering Milwaukee's Freddy Peralta, who is coming off a strong season with a 2.70 ERA and 17 wins. Additionally, the Yankees have signed veteran
infielder Paul DeJong to a minor league deal, potentially filling a gap at shortstop due to Anthony Volpe's injury.
Why It's Important?
The Yankees' pursuit of Edward Cabrera highlights their urgent need to strengthen their pitching roster amid significant injuries. Cabrera's acquisition could provide the Yankees with a young, controllable arm, crucial for maintaining competitiveness in the upcoming season. However, his injury history poses a risk. The potential addition of Freddy Peralta, a proven performer, could further solidify the Yankees' rotation. The signing of Paul DeJong offers depth and flexibility in the infield, addressing potential gaps due to injuries. These moves reflect the Yankees' strategic efforts to navigate challenges and remain contenders in the highly competitive MLB landscape.
What's Next?
The Yankees will likely continue negotiations with the Marlins and Brewers to finalize potential trades for Cabrera and Peralta. The outcome of these discussions will significantly impact the Yankees' pitching strategy for the upcoming season. Meanwhile, Paul DeJong's performance in spring training will determine his role in the Yankees' lineup. The team's management will need to balance immediate needs with long-term planning, considering both player health and financial implications.
